These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen. Kuroda K, Yagi J, Imanishi K, Yan XJ, Li XY, Fujimaki W, Kato H, Miyoshi-Akiyama T, Kumazawa Y, Abe H, Uchiyama T. J Immunol; 1996 Aug 15; 157(4):1422-31. PubMed ID: 8759722 [Abstract] [Full Text] [Related]
11. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18. Tomura M, Maruo S, Mu J, Zhou XY, Ahn HJ, Hamaoka T, Okamura H, Nakanishi K, Clark S, Kurimoto M, Fujiwara H. J Immunol; 1998 Apr 15; 160(8):3759-65. PubMed ID: 9558078 [Abstract] [Full Text] [Related]
15. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells. Noble A, Pestano GA, Cantor H. J Immunol; 1998 Jan 15; 160(2):559-65. PubMed ID: 9551888 [Abstract] [Full Text] [Related]
16. Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (beta-chain) transgenic mice. Perkins DL, Wang Y, Ho SS, Wiens GR, Seidman JG, Rimm IJ. J Immunol; 1993 May 15; 150(10):4284-91. PubMed ID: 8097752 [Abstract] [Full Text] [Related]
17. Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T cells. Arase-Fukushi N, Arase H, Ogasawara K, Good RA, Onoé K. J Immunol; 1993 Nov 01; 151(9):4445-54. PubMed ID: 8104995 [Abstract] [Full Text] [Related]
18. Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells. Bhandoola A, Cho EA, Yui K, Saragovi HU, Greene MI, Quill H. J Immunol; 1993 Sep 01; 151(5):2355-67. PubMed ID: 8103063 [Abstract] [Full Text] [Related]